All In Biotech

Free tool

FAERS Monitor: Invega

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021999 or its brand name (Invega, Paliperidone). Reports on generic versions are filed under their own applications.

Reports

23,466

Serious

11,599

49% of reports

Hospitalization

4,806

Death reported

845

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • injury4,330
  • gynaecomastia3,666
  • drug ineffective1,795
  • abnormal weight gain1,662
  • off label use1,565
  • weight increased1,390
  • hyperprolactinaemia1,272
  • galactorrhoea1,060
  • sedation762
  • dyskinesia717
  • dystonia715
  • treatment noncompliance684
  • suicide attempt672
  • schizophrenia670
  • product use in unapproved indication632

Reports by year received

View as table
YearReports
2007696
2008743
2009650
2010524
2011687
2012783
2013652
2014966
20152,359
20164,208
20173,453
2018910
2019847
2020814
2021812
2022932
2023924
2024801
20251,024
2026681

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,693 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperprolactinaemiaSignal1,272218.5205.8221,318
galactorrhoeaSignal1,060176.9165.8154,743
abnormal weight gainSignal1,662139.2132.4197,338
gynaecomastiaSignal3,666120.3116.5382,964
injurySignal4,33058.857.1231,430
schizophreniaSignal67052.248.431,793
dystoniaSignal71534.331.822,230
sedationSignal76226.825.018,396
dyskinesiaSignal71716.115.09,965
treatment noncomplianceSignal68411.310.56,372
suicide attemptSignal67210.09.35,412
weight increasedSignal1,3905.65.35,260
product use in unapproved indicationSignal6322.32.1462
off label use1,5651.61.5369
drug ineffective1,7951.21.276

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.